Covered recipient · General Payments record
CARMEN TERLIZZI
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2019
$943.89
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $259.11 | 13 |
| Education | $40.75 | 2 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CooperSurgical, Inc. | $75.04 | 1 |
| AMAG Pharmaceuticals, Inc. | $40.75 | 2 |
| PFIZER INC. | $36.94 | 3 |
| Avion Pharmaceuticals | $32.27 | 2 |
| TherapeuticsMD, Inc. | $28.40 | 2 |
| ABBVIE INC. | $24.62 | 1 |
| Astellas Pharma US Inc | $18.08 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.28 | 1 |
| Olympus America Inc. | $13.30 | 1 |
| Avanos Medical | $13.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie, Inc. | $24.62 | 04/02/2019 | Food and Beverage | Undisputed | 01/23/2026 | 647908749 | CMS |
| AMAG Pharmaceuticals, Inc. | $20.20 | 04/23/2019 | Education | Undisputed | 01/23/2026 | 698540709 | CMS |
| AMAG Pharmaceuticals, Inc. | $20.55 | 05/31/2019 | Education | Undisputed | 01/23/2026 | 698540711 | CMS |
| Astellas Pharma US Inc | $18.08 | 01/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | 655776921 | CMS |
| Avanos Medical | $13.18 | 01/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | 705118737 | CMS |
| Avion Pharmaceuticals | $14.51 | 01/08/2019 | Food and Beverage | Undisputed | 01/23/2026 | 702485577 | CMS |
| Avion Pharmaceuticals | $17.76 | 06/25/2019 | Food and Beverage | Undisputed | 01/23/2026 | 702494293 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $17.28 | 04/09/2019 | Food and Beverage | Undisputed | 01/23/2026 | 628418677 | CMS |
| CooperSurgical, Inc. | $75.04 | 02/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | 693964695 | CMS |
| Olympus America Inc. | $13.30 | 03/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | 701504653 | CMS |
| PFIZER INC. | $12.20 | 02/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | 671893995 | CMS |
| PFIZER INC. | $11.88 | 03/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | 672003529 | CMS |
| PFIZER INC. | $12.86 | 05/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | 672267053 | CMS |
| TherapeuticsMD, Inc. | $14.20 | 03/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | 703082703 | CMS |
| TherapeuticsMD, Inc. | $14.20 | 04/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | 703082705 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.